Aug. 20, 2026 — The Society of Surgical Oncology (SSO) will adopt a four-tier international dues structure based on World Bank income classifications for the 2027 dues cycle and all foreseeable dues cycles. The change is intended to better align membership dues with regional economic conditions and support SSO’s strategic goal of expanding international engagement. Additionally, SSO will
ROSEMONT, Ill., Aug. 12, 2026 — The Society of Surgical Oncology (SSO) today announced the inaugural E. Shelley Hwang Sustainability Excellence Grant, created to recognize surgical oncologists who demonstrate exceptional leadership and measurable impact in advancing environmental sustainability within their clinical practice, institution or health system. The first-of-its-kind grant will provide $10,000 in funding for initiatives focused on operating room
The David L. Bartlett Legacy Award recognizes an early career faculty/emerging leader who demonstrates a strong trajectory of transformative contributions in education, mentorship, and innovation in advanced cancer therapies. Named in honor of Dr. David L. Bartlett, founder of the Advanced Cancer Therapies (ACT) Meeting, the award celebrates his visionary leadership and lasting impact on the field of regional and
ROSEMONT, Ill., Aug. 7, 2026 — The Society of Surgical Oncology (SSO) is pleased to announce the new David L. Bartlett Legacy Award, named in honor of David L. Bartlett, MD, founder of the Advanced Cancer Therapies (ACT) Meeting, whose visionary leadership has shaped the field of regional and advanced cancer treatment. Dr. Bartlett serves as Chair of the
ROSEMONT, Ill., Aug. 6, 2026 — The Society of Surgical Oncology (SSO) and the Melanoma Research Alliance (MRA) today announced a collaborative Young Investigator Award, jointly funded by both organizations. SSO and MRA intend to support one award through the partnership. Young Investigator Awards aim to attract early-career faculty with original ideas into the field
When Postmastectomy Radiotherapy (PMRT) Is Not Really PMRT: A Critical Evaluation of SUPREMO Trial Authors: George E. Naoum MD, MMSCI & Alphonse G. Taghian MD, PHD Date of Acceptance: February 26, 2026. Expert Commentary: The SUPREMO trial reported that chest-wall-irradiation alone did not improve disease-free or overall survival. The lessons learned depend on which patients
Our Mission The mission of the Society of Surgical Oncology is to improve multidisciplinary patient care by advancing the science, education and practice of cancer surgery worldwide. Our Values Professionalism Advocate for the cancer patient through integrity and ethical conduct. QualityFoster quality through improved understanding of cancer biology, compassionate communication and optimizing outcomes across the continuum
The Society of Surgical Oncology (SSO) today announced a significant increase in funding for its 2027 Clinical Investigator Award (CIA) and Young Investigator Award (YIA), underscoring the organization’s commitment to advancing oncological research. Beginning with the 2027 award cycle, CIA funding will increase to $150,000 over two years, up from $100,000. YIA funding will increase
The Annals of Surgical Oncology’s, The Landmark Article Series, has quickly become a leading resource that demonstrates the logical progression of clinical trials and key evidence leading up to current multidisciplinary therapy. Articles and links to abstracts are listed below. SSO Mobile users: You may download articles by visiting the Annals of Surgical Oncology link
